Prague Med. Rep. 2020, 121, 254-261
https://doi.org/10.14712/23362936.2020.22
A Successful Treatment of Encapsulating Peritoneal Sclerosis in an Adolescent Boy on Long-term Peritoneal Dialysis: A Case Report
References
1. 2009) Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin. Pract. 111(2), c149–154; discussion c154.
< , T., Brown, P. W., Davies, S. D., Summers, A. M., Wilkie, M. E. (https://doi.org/10.1159/000191214>
2. 2009) The Pan-Thames EPS study: Treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol. Dial. Transplant. 24(10), 3209–3215.
< , G., Brown, E. A., Davenport, A., Cairns, H., Cooper, B., Fan, S. L., Farrington, K., Gallagher, H., Harnett, P., Krausze, S., Steddon, S. (https://doi.org/10.1093/ndt/gfp008>
3. 2009) Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin. J. Am. Soc. Nephrol. 4(7), 1222–1229.
< , M. C., Simpson, K., Kerssens, J. J., Mactier, R. A.; Scottish Renal Registry (https://doi.org/10.2215/CJN.01260209>
4. 1998) Sclerosing encapsulating peritonitis: Early and late results of surgical management in 32 cases. French Associations for Surgical Research. Dig. Surg. 15(6), 697–702.
, B., Levard, H., Hay, J., Msika, S., Fingerhut, A., Pelissier, E. (
5. 2011) Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data. Int. Urol. Nephrol. 43(1), 147–156.
< , T., Oreopoulos, D. G. (https://doi.org/10.1007/s11255-010-9744-5>
6. 2005) Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients. Nephrology (Carlton) 10(4), 341–343.
< , M., Fitoz, S., Yagmurlu, A., Ensari, A., Yuksel, S., Acar, B., Ozcakar, Z. B., Kendirli, T., Bingoler, B., Yalcinkaya, F. (https://doi.org/10.1111/j.1440-1797.2005.00416.x>
7. 2007) Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit. Dial. Int. 27(6), 619–624.
< , M. W., Betjes, M. G., Korte, M. R., Boer, W. H. (https://doi.org/10.1177/089686080702700603>
8. 1980) Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch. Intern. Med. 140(9), 1201–1203.
< , V. C., Humayun, H. M., Ing, T. S., Daugirdas, J. T., Jablokow, V. R., Iwatsuki, S., Geis, W. P., Hano, J. E. (https://doi.org/10.1001/archinte.1980.00330200077024>
9. 2000) Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients. Pediatr. Nephrol. 14(4), 275–279.
< , S., Honda, M., Itami, N., Oh, S., Matsumura, C., Moriya, S., Mori, M., Hatae, K., Ito, Y., Karashima, S. (https://doi.org/10.1007/s004670050758>
10. 2019) Encapsulating peritoneal sclerosis: Pathophysiology and current treatment options. Int. J. Mol. Sci. 20(22), 5765.
< , R. M., Bozikas, A., Zarogiannis, S. G., Bartosova, M., Schmitt, C. P., Liakopoulos, V. (https://doi.org/10.3390/ijms20225765>
11. 1992) Biocompatibility of peritoneal dialysis fluids. Int. J. Artif. Organs 15(2), 79–83.
< , A., Topley, N., Gahl, G. M. (https://doi.org/10.1177/039139889201500203>
12. 2000) Encapsulating peritoneal sclerosis: Definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit. Dial. Int. 20, S43–S55 (Suppl. 4).
< , Y., Kawanishi, H., Mujais, S., Topley, N., Oreopoulos, D. G. (https://doi.org/10.1177/089686080002004S04>
13. 2012) Surgical and medical treatments of encapsulation peritoneal sclerosis. Contrib. Nephrol. 177, 38–47.
< , H. (https://doi.org/10.1159/000336934>
14. 2005) Epidemiology of encapsulating peritoneal sclerosis in Japan. Perit. Dial. Int. 25, S14–S18 (Suppl. 4).
< , H., Moriishi, M. (https://doi.org/10.1177/089686080502504S03>
15. 2004) Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am. J. Kidney Dis. 44(4), 729–737.
< , H., Kawaguchi, Y., Fukui, H., Hara, S., Imada, A., Kubo, H., Kin, M., Nakamoto, M., Ohira, S., Shoji, T. (https://doi.org/10.1016/S0272-6386(04)00953-9>
16. 2005) Successful surgical management of encapsulating peritoneal sclerosis. Perit. Dial. Int. 25, S39–S47 (Suppl. 4).
< , H., Watanabe, H., Moriishi, M., Tsuchiya, S. (https://doi.org/10.1177/089686080502504S06>
17. 2011) Seventeen years’ experience of surgical options for encapsulating peritoneal sclerosis. Adv. Perit. Dial. 27, 53–58.
, H., Shintaku, S., Moriishi, M., Dohi, K., Tsuchiya, S. (
18. 1990) Surgical aspects of sclerosing encapsulating peritonitis. Arch. Surg. 125(12), 1626–1628.
< , D. S., Korpe, S. W., Raytch, R. E., Smith, G. W. (https://doi.org/10.1001/archsurg.1990.01410240108022>
19. 2011) Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol. Dial. Transplant. 26(2), 691–697.
< , M. R., Fieren, M. W., Sampimon, D. E., Lingsma, H. F., Weimar, W., Betjes, M. G.; investigators of the Dutch Multicentre EPS Study (https://doi.org/10.1093/ndt/gfq362>
20. 2009) Diagnosis and surgical management of abdominal cocoon: results from 12 cases. Acta Gastroenterol. Belg. 72(4), 447–449.
, H. Y., Wang, Y. S., Yang, W. G., Yin, S. L., Pei, H., Sun, T. W., Wang, L. (
21. 2014) Encapsulating peritoneal sclerosis – A rare but devastating peritoneal disease. Front. Physiol. 5, 470.
, Z., Summers, A., Van Dellen, D., Augustine, T., Herrick, S. E. (
22. 2005) Encapsulating peritoneal sclerosis – A clinician’s approach to diagnosis and medical treatment. Perit. Dial. Int. 25, S30–S38 (Suppl. 4).
< , H. (https://doi.org/10.1177/089686080502504S05>
23. 2001) Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int. Suppl. 78, S42–S47.
< , J., Hermann, S., Fusshöller, A., Schoenicke, G., Donner, A., Röhrborn, A., Grabensee, B. (https://doi.org/10.1046/j.1523-1755.2001.59780042.x>
24. 2005) The abdominal cocoon and an effective technique of surgical management. Trop. Gastroenterol. 26(1), 51–53.
, I., Mathew, G., Sitaram, V., Perakath, B., Rao, A., Nair, A. (
25. 2007) Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content. Nephrol. Dial. Transplant. 22(7), 2038–2044.
< , C. P., von Heyl, D., Rieger, S., Arbeiter, K., Bonzel, K. E., Fischbach, M., Misselwitz, J., Pieper, A. K., Schaefer, F.; Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS) (https://doi.org/10.1093/ndt/gfm148>
26. 2013) Encapsulating peritoneal sclerosis in children on chronic PD: A survey from the European Paediatric Dialysis Working Group. Nephrol. Dial. Transplant. 28(7), 1908–1914.
< , R., Stefanidis, C. J., Askiti, V., Edefonti, A., Testa, S., Ekim, M., Kavaz, A., Ariceta, G., Bakkaloglu, S., Fischbach, M., Klaus, G., Zurowska, A., Holtta, T., Jankauskiene, A., Vondrak, K., Vande Walle, J., Schmitt, C. P., Watson, A. R.; European Paediatric Dialysis Working Group (https://doi.org/10.1093/ndt/gfs603>
27. 2005) Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis. J. Pediatr. Surg. 40(5), e21–e23.
< , F. L., Loh, D., Prabhakaran, K. (https://doi.org/10.1016/j.jpedsurg.2005.02.015>
28. 2010) The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis. Perit. Dial. Int. 30(3), 343–352.
< , T., Nagasue, K., Okuno, S., Yamakawa, T. (https://doi.org/10.3747/pdi.2008.00273>